D-Target enters folds of pharma CRO Premier Research, but holds strong to medtech focus
This article was originally published in Clinica
Executive Summary
D-Target's CEO has told Clinica that the medical devices CRO will remain "committed and focused on devices" and its expertise will not be "diluted" by its largely pharma-focused acquirer, Premier Research Group (PRG).